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Abstract
Prefilled syringes are currently available as treatment options for individuals with diabetes,
allergies, and other medical conditions mandating delivery of drugs by injection. However current prefilled
syringes are often bulky, conspicuous, require specific storage conditions, and may prematurely deploy.
Because of these factors, patients may be less compliant to treatment regimens and feel that their lifestyles
and independence are inhibited. The newly designed prefilled syringe should be portable, practical, and
easy-to-use. This project will be completed for Bionix Corporation located in Toledo, OH. Our contacts at
this company are Mr. Ed Markewitz, Product Development Program Manager, and Mr. Cody Harder,
Product Development Engineer. Cody Harder has served as our main contact throughout the duration of the
project. The purpose of this project is to develop a prefilled syringe for Bionix that competes with currently
available syringes. Currently, Bionix has no such product, as they mainly specialize in radiation therapy
equipment. Bionix also has a Medical Technologies division that makes disposable medical instruments,
and Bionix is looking for a syringe product that it may sell and distribute to drug companies. Through the
design of the new prefilled syringe, Stringent Syringes intends to improve the quality of existing products
from a patient perspective my enhancing ease of use and making the syringe less conspicuous than existing
products. Stringent Syringes has completed this project by designing a compact and user-friendly prefilled
syringe using a folding plunger to reduce the overall size of the device. The newly designed syringe is
portable, able to withstand considerable mechanical forces, and meets the criteria established in the
literature by users of prefilled syringes.
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Introduction
Problem Statement
Prefilled syringes are currently available as treatment options for individuals with diabetes,
allergies, and other medical conditions mandating delivery of drugs by injection. However, current prefilled
syringes are often bulky, conspicuous, require specific storage conditions, and may prematurely deploy.
Because of these factors, patients may be less compliant to treatment regimens and feel that their lifestyles
and independence are inhibited. The newly designed prefilled syringe should be portable, practical, and
easy-to-use.

Customer Information
This project will be completed for Bionix Corporation located in Toledo, OH. Our contacts at this
company are Mr. Edward Markewitz, Product Development Program Manager, and Mr. Cody Harder,
Product Development Engineer. Cody Harder has served as our main contact throughout the duration of the
project.

Purpose of Project
The purpose of this project is to develop a prefilled syringe for Bionix that competes with currently
available syringes. Currently, Bionix has no such product, as they mainly specialize in radiation therapy
equipment. Bionix also has a Medical Technologies division that makes disposable medical instruments,
and Bionix is looking for a syringe product that it may sell and distribute to drug companies. Through the
design of the new prefilled syringe, Stringent Syringes intends to improve the quality of existing products
from a patient perspective by enhancing ease of use and making the syringe less conspicuous than existing
products.
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Background Information
Prefilled syringes date back to the 1970s as injectable drug delivery devices in many applications,
and the market is expected to grow 12.8% per year (Longworth, 2009; Soikes, 2009). More than 13 million
injection devices are used daily for insulin alone (Gold, 2011). As a result, multiple prefilled injection
devices exist for every-day use.
Although daily medication administration has become a minute part of everyday life for most
patients, there is well-documented evidence suggesting that prefilled syringes have many unstated social
implications that are important to patients. In order to maintain high rates of patient adherence to treatment
regimens, patients must feel comfortable using their syringes (Anderson & Redondo, 2011). For example,
diabetics who are expected to self-administer two doses of insulin daily may be less inclined to pursue this
regulated treatment schedule if they feel uncomfortable or embarrassed to use their products. In addition,
if syringes are user-friendly, administration of drugs may not require the assistance of caregivers for
children or elderly individuals. In turn, self-confidence in patient self-administration will be improved. The
physical appearance of syringes also influences use; much psychological research has been devoted to
understanding a common fear of needles that affects many patients who require blood tests, infusions, or
injections (Anderson & Redondo, 2011). One design aspect that has been largely ignored by many
manufacturers of prefilled syringes is size and portability. A small, lightweight, and inconspicuous syringe
is more likely to be carried by users (Anderson & Redondo, 2011). It also appears that patients prefer colorcoded syringes that make dosing fast and simple (Anderson & Redondo, 2011). For those patients for whom
the self-administration of drugs may be difficult, such as elderly individuals or patients with visual
complications caused by diabetes, a large display or loud clicking noise may assist with accurate dosing
(Antinori-Lent, 2012). These patient considerations must be made when designing a new device.

Objectives and Goals
Throughout the development process, Stringent Syringes achieved multiple goals. Within the team,
we have sought to come prepared to weekly meetings, to complete literature searches, and to solve conflicts
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in a professional manner while considering our customer’s needs. We have considered our customers to be
Bionix as the company who originally requested the novel design, primary users of prefilled syringes,
healthcare personnel, caregivers, and military personnel. Stringent Syringes also aimed to keep in contact
with Bionix throughout the process with regular meetings and updates.
The design process has required Stringent Syringes to determine various requirements for a new
prefilled syringe design. The main objective has been to create an inconspicuous prefilled syringe that will
be discrete and portable. Our designs have been oriented toward improving user confidence and treatment
compliance. Functionally, the syringe should deploy easily, withstand mechanical forces required for
injection, dispense the drug reliably, and have a compact design. On the material side, the syringe should
be constructed from biocompatible materials that cause no allergic reactions or immune response. The
materials should not absorb the drug, should be lightweight for transportation and easy use, and be able to
withstand reasonable temperature changes in a typical living environment. FDA regulations have also been
considered as a requirement.
Bionix has dictated few constraints and limitations on the design. They have not provided material
constraints other than “FDA compliance,” nor have they identified a specific injection site, customer, or
disease treatment targets for the product. They are primarily interested in pursuing a device that will be
appealing to drug companies as a novel, minimally-sized syringe.
Throughout the design process, different objectives and requirements were added to our original
goals. Some of these features included manufacturing the syringe to include a minimal number of parts and
inclusion of safety features to prevent malfunction or premature deployment.

Methods and Procedures
Stringent Syringes began its fall semester by compiling the prior knowledge of its members in order
to gain a working definition of the problem at hand. Each member performed an independent literature
search for a different facet of the project, and we merged these results in order to obtain a functional
understanding of the project and its prerequisites. Upon our first meeting with our customer, we prepared a
4

series of preliminary questions to ask Bionix. We met with Mr. Edward Markewitz and Mr. Cody Harder,
the Product Development Program Manager and a Product Development Engineer, respectively. This
meeting was the first time that Bionix elucidated their expectations concerning our project, our final
prototype device, and our team.
During this meeting, we specifically inquired if Bionix had any prefilled syringe products on the
market as of present. They did not. This was Bionix’s first investigation into developing a prefilled syringe
product. Bionix requested that we make an appealing prefilled syringe design in hopes of ultimately adding
the prefilled syringe to their product line. They briefly mentioned a foldable plunger design. We
acknowledged that we had already considered this idea. Bionix stated that they had no specific medical
need for which they were creating the syringe, but would like to design a product that would be popular
based on total number of syringe uses. This request, in combination with our subsequent literature review,
directed our decision to pursue an insulin delivery device.
A literature and patent search revealed that most user complaints with insulin delivery products are
that they are difficult to use for patients with limited dexterity and that syringes are painful to use and
oftentimes bulky, conspicuous, and inconvenient. In order to solve some of these patient-identified
problems with syringes, we investigated alternative injection technologies, such as jet-stream injection and
powder injection syringes. We also created a survey that we distributed to users of prefilled syringes and
prefilled pens in order to understand the benefits and drawbacks of current devices. We believed that
directly requesting this information from syringe and pen users was the most reliable way to design a
desirable product. Table 1 provides a summary of the questions provided on the survey and of the
percentage of surveyed individuals that responded “yes” to each question. Figure 1 is a bar chart
summarizing the most prominent responses to our survey. These responses formed the basis of our
subsequent additions to functional requirements in the spring.
We began the spring semester by meeting with Bionix over Skype to deliver a presentation which
expressed our progress to-date. We agreed with Bionix to pursue a prefilled insulin syringe due to its
popular and widespread usage. We also presented some basic sketches of designs we discussed the week
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prior to this meeting. These designs included: 1. a syringe with telescoping plunger, 2. a syringe with a
foldable plunger, 3. a syringe with an air pump, and 4. a syringe with spring pump, 5. a needleless syringe
with an air pump, 6. a needleless syringe with a spring pump, and 7. a needleless syringe powered by
pyrotechnics. During our meeting, Cody expressed his opinion that Bionix would prefer to keep the prefilled
syringe as simple as possible, which ruled out further pursuit of a needleless injection system. Bionix also
expressed that the syringe should not be reusable, but disposable; therefore, it was necessary that the device
incorporate changeable dosing. We discussed that we would move forward with two of these ideas, the
syringes with telescoping and foldable plungers. We then distributed different tasks among members of the
group. During product development, we discovered a third low-cost, simple design. Thus, we drafted three
basic syringe designs: 1. a syringe with a foldable plunger (Figure 2), 2. a syringe with a telescoping
component (Figure 3), and 3. a syringe with a screw-on plunger (Figure 4).
Additional requirements were added to the models. These included criteria such as needle length
and needle gauge. From our research, a needle length of 6 mm and a needle gauge of 30 were selected for
use in the SolidWorks models (Syringe and Pen Needle Sizes, 2015). Similarly, we discussed that in order
to accommodate the comfort of patients, we must consider a pointed or rounded barrel end in our design
(Syringe and Pen Needle Sizes, 2015). Another consideration we decided to pursue is that insulin must be
monitored to make sure it remains in solution (Storing Insulin and Prefilling Syringes, 2014).
At this point, Stringent Syringes was faced with a difficult design complication. We were trying to
find a way to make a disposable syringe with varying insulin dosage volumes. These dosages changed for
each customer and multiple times a day per customer. We looked at different options such as a single
changeable cartridge to dispense varying amounts, different size cartridges, and multiple cartridges for a
single dose. After further research into the specific insulin dosages, we realized that this field is has been
thoroughly optimized for insulin dosages in other syringes such as the prefilled pens.
Later in the semester, Bionix suggested that we design the syringe for a “hypothetical drug X”
(such as a vaccine) that would dispense a larger, consistent volume and also suggested that we avoid
designing an insulin-specific syringe. From this point forward, insulin-specific delivery was not considered
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in our device design. Rather, we moved forward by considering our device as a delivery vehicle for
“hypothetical drug X.” Stringent Syringes, along with Bionix, decided to evaluate our options between the
folding and screw-on plunger designs and to choose one. We then decided to explore patents similar to the
screw-on syringe to evaluate the similarities between those designs and ours. In doing so, we ruled out the
screw-on design, and as a team, we decided to pursue the folding syringe design.
We completed a re-design of the folding syringe to incorporate the changes that would be needed
to make this device applicable to “hypothetical drug X” instead of insulin. These changes included making
the plunger fold into the finger holds on the syringe and increasing the syringe volume to hold a standard
vaccine dosage. We designed the syringe with the intention of delivering a hypothetical vaccine due to
Bionix’s implication that our device may be good for vaccines that have a volume of about 3mL. We
discussed other potential design improvements resulting in an addition of a safety feature: to have a ridge
that allows the plunger to snap into the hold for a secure fit. This will decrease any risk of the syringe
unfolding or deploying prematurely. With slight design changes, we reduced the overall number of parts
for the device by discussing the possibility of molding the pins into another piece. Stringent Syringes
presented the improved folding plunger syringe design to Bionix as shown in Figure 5. Bionix approved
the design with the suggestion that we add a “step” piece to the syringe finger hold in order to prevent
accidental deployment. We agreed to add this piece to the design and finalized the design in Figure 6 before
prototyping.
We ordered a prototype of this design from Shapeways. The design was 3D printed from frosted
ultra-detail plastic and was quickly delivered (less than two weeks). Upon initial inspection of the folding
mechanism, our design successfully operated as intended. However, our prototype was too small. We then
realized that our model’s barrel diameter was only half of the intended barrel diameter. Figure 7 displays
the new prototype we ordered with correct dimensions, requiring a slight redesign.
After the completion of the prototype, a notable patent was discovered. Previous patent searches
for foldable syringes turned up some syringes with the needle and cap hinged and not the plunger (Patent
No. US8038654B2, 2011), syringes with the body folding for drug loading (Patent No. US2871858A,
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1959), and syringes with collapsible chambers that fold along specific lines (Patent No. CA1057150A1,
1979). One particular patent, “Hypodermic syringe with articulate plunger,” came into question “This
syringe looks similar in design with a folding plunger, but has several key differences. Mainly, the syringe
does not have a quarter-lock mechanism to lock the plunger in place when it extends. When the plunger is
folded upwards, the plunger starts to depress through the plunger, indicating drug release during the folding
mechanism. The Stringent Syringes’ design allows the plunger to be fully extended and depressed before
drug delivery can ensue, similar to current syringes used on the market. We created a product more within
the range of the user’s comfort levels. Also, this articulate plunger design does not fold into the thumb grips
but rather surpasses them. To lock the plunger, this syringe has a clamp fastened fully around the barrel,
extending the overall size and limiting maneuverability. This syringe also folds the material itself instead
of rotating around pins, creating a weakness in the system (Patent No. US4011868 A, 1977). Overall,
Stringent Syringes notices the design similarity, but we believe our design to be a significant addition to
the current market.

Manufacturing
Stringent Syringes did not have the funds or means to pursue practical manufacturing. However,
the product was designed with future manufacturing in mind. The original designs for our product contained
up to nine individual parts that had to be assembled into the final product. By incorporating the pins into
the other components, we were able to decrease the total number of components down to seven. Fewer parts
are typically easier for manufacturing. However, because the pins used in our design are small, it may be
difficult to design a manufacturing process that can assemble the parts. Thus, the nine-component system
may prove to be a more manufactural model. Additionally, in order to decrease costs, our current system
used polyethylene for the incorporated pins. The mechanical stabilities of the pins and of the overall design
could be improved by using stainless steel pins. However, stainless steel pins could only be incorporated
by either 1) making the parts incorporating the pins out of stainless steel, or 2) increasing the total number
of parts to nine.
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Other considerations include the addition of the second cut under the finger grips. The symmetry
on both sides of the syringe allows for easier manufacturing when the part is not directionally oriented. The
parts were also designed in a fashion similar to syringes currently on the market. A manufacturer would
make minimal changes to incorporate the folding plunger into the system.

Performance Testing
Functional Testing
Using our prototype, we confirmed that our folding mechanism works as designed. The plunger
audibly clicks into the side of the syringe, and once the plunger is extended, the quarter lock turn locks
the system in place before depression. The plunger depresses fully through the syringe barrel. We also
confirmed that the dimensions were correct based on the volume the syringe could potentially hold, 3 mL
for this particular design. However, the syringe dimensions could be adjusted for a wide range of
volumes.
In Silico Mechanical Testing
Because the prototype could not be 3D printed using polyethylene due to material options through
Shapeways and 3D printed models are known to be very brittle, we performed mechanical testing in
SolidWorks. In order to develop our model, we assumed that we would be injecting patients with a volume
of 3 mL. We assumed that the time for the injection to occur would take somewhere between 1.25 and 10
seconds. We also assumed a worst case scenario; the injection would be intravenous such that the pressure
resisting the injection of fluid would be equal to blood pressure. The value used for standard blood pressure
was assumed to be 120 mmHg, which is approximately 16 kPa. To calculate the pressure required to inject
3 mL of fluid within 1.25 seconds, we first calculated the necessary volumetric flow rate according to the
equation:
𝑄1 = 𝑉/𝑡

(Eq. 1)

where Q1 is the volumetric flow rate (m3/s) through the needle, V is the volume of the fluid to be injected
(m3), and t is the time required to inject (s). As stated above, we assumed that V was 3 mL and that t was
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between 1.25 and 10 seconds. The volumetric flow rate through the needle (Q1) is equal to the volumetric
flow rate out of the syringe body (Q2):
𝑄1 = 𝑄2

(Eq. 2)

The velocity of the fluid could then be calculated using the equation:
𝑄2 = 𝐴2 𝑣2

(Eq. 3)

alternatively arranged as:
𝑣2 =

𝑄2
𝐴2

(Eq. 4)

where Q2 is the volumetric flow rate out of the syringe body, A2 is the cross sectional area of the syringe
body, and v2 is the straight-line velocity of the fluid out of the syringe body. Using the straight-line velocity
of the fluid, we calculated the pressure required to move the fluid according to Bernoulli’s Equation:
𝑃1 +

1
𝜌𝑣12
2

+ 𝜌𝑔ℎ1 = 𝑃2 +

1
𝜌𝑣22
2

+ 𝜌𝑔ℎ2

(Eq. 5)

where P1 is the pressure at the outlet of the needle, P2 is the pressure at the outlet of the syringe body, 𝜌 is
the density of blood (assumed to be 1035 kg/m3), v1 is the velocity of the fluid exiting the needle, v2 is the
velocity of the fluid exiting the syringe body, 𝑔 is the gravitational constant 9.81 m/s2, h1 is the height of
the needle, and h2 is the height of the fluid in the syringe. The density of blood was used instead of the
density of water because the density of blood is presumably closer to the density of injectables, which may
contain proteins, cells, small molecules, or even drug delivery systems. By assuming that the syringe is held
horizontally during the injection, h1 = h2, Eq. 5 simplifies to:
𝑃1 +

1
𝜌𝑣12
2

= 𝑃2 +

1
𝜌𝑣22
2

(Eq. 6)

1
𝜌𝑣22
2

1
2

(Eq. 7)

Solving for P1:
𝑃1 = 𝑃2 +

− 𝜌𝑣12

Written alternatively as:
𝑃1 = 𝑃2 +

1
𝜌(𝑣22
2

− 𝑣12)

(Eq. 8)
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The results were calculated for times ranging from 1.25 to 10 seconds. The results are shown in
Table 2 with pressures ranging from 0.13 – 7.58 MPa. The calculated pressures, in units of Pascals, were
used in the SolidWorks simulation. The simulation was designed as follows: all parts of the syringe were
assembled into an assembly file, and mates were added to align the parts in the correct order. The needle of
the syringe was designed from AISI 321 Annealed Stainless Steel. The plunger was designed to be made
from polyisoprene. All other components were designed from low density polyethylene. The mechanical
properties for AISI 321 Annealed Stainless Steel are provided in SolidWorks. The mechanical properties
of polyethylene and polyisoprene were defined manually. All mechanical properties used in the simulations
are reproduced in Table 3.
The mechanical testing simulations were performed using the Simulation add-in within
SolidWorks. To build the simulation, the syringe body grip and the top surface of the plunger shaft were
“fixed” in space, which makes them rigid and unable to move or deform. These surfaces were chosen as
the fixation points because they are the points at which the syringe will be held. Presumably, the pressure
exerted by the human hand will limit movement at the top of the shaft and at the gripper. Pressures were
then applied to all surfaces within the syringe body, according to the values provided in Table 1. Placements
of the fixation surfaces and of the applied pressures are shown in Figure 8. A solid mesh based on curvature
with four Jacobian points was applied to the body. Using that mesh, 108107 nodes were defined with 67221
connections. For a visualization of the meshing, please refer to Figure 9.
The simulations were run using different time parameters, and the minimum factor of safety was
determined. A power regression was fit to the data, which had a R2 coefficient of determination equal to
0.9997. As shown in Figure 10, the minimum factor of safety was 14. Using the regression, the time of
injection required to reach a factor of safety of 2 was 0.447 seconds, and the time of injection required to
reach a factor of safety of 1 was 0.313 seconds. These data suggest that, in order for our current design to
fail, a patient with normal blood pressure would need to be injected with 3 mL of fluid within 313
milliseconds, an extremely fast injection rate.
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To determine where the syringe is most likely to fail, the stress and strain intensities were
calculated. As shown in Figure 11, the maximum stress occurs within the walls of the syringe body,
indicating that the rupture of the syringe body would be one likely mode of failure. If higher pressures are
required, the syringe body thickness could be increased to withstand the additional stresses. Stress is also
relatively high within the core of the shaft. Importantly, most of the stress is carried by the core of the shaft
and not by the shell. This means that the quarter locking system (which is relatively delicate) does not bare
much of the stress and is therefore unlikely to be the cause of system failure. Stress risers are apparent in
the corners of some of the notches cut for the quarter lock systems. Those risers could likely be decreased
by rounding those corners.
The maximum strain intensity was also calculated, and it is displayed in Figure 12. The maximum
strain occurs in the plunger, largely due to the fact that it is made from non-rigid polyisoprene. Polyisoprene
was used in our design because it has been used elsewhere for plungers. Two design changes could
dramatically decrease strain in the plunger. Firstly, the polyisoprene could be changed to a more rigid
material, such as rubber, another commonly used plunger material. Secondly, the plunger could be made of
a more rigid material, such as low density polyethylene, with a small band of polyisoprene providing the
seal.

Future Directions
Due to time and funding constraints, Stringent Syringes could not continue testing beyond
simulation and simple verification and validation testing. Assuming we had the opportunity, this syringe
would be placed under a multitude of testing procedures before becoming a usable product. First, working
prototypes would be created with ideal features such as the proper polymer, polyethylene, and the proper
size needle. Other features could be added to the syringe in accordance with user and FDA standards such
as proper labeling and graduation lines, color coordinated parts, and user instructions (Guidance for industry
and FDA staff: Medical devices with sharps injury protection features, 2005).
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To use this syringe, it would need to pass ISO testing. Specifically ISO/TC 76, used for all
transfusion, infusion and injection, and blood processing equipment for medical and pharmaceutical use
(ISO, 1951). ISO 11040 consists of various standards for prefilled syringes including glass cylinders,
plungers, disks, and aluminum caps for dental local anesthetics. This standard also tests for glass barrels,
plungers, and plastic barrels for injectable (ISO, 2015).
Other considerable standards include ISO 7886-1 for sterile hypodermic syringes for single use
(ISO, 2015) and ISO 8537 for sterile single-use syringes, with or without needles, for insulin which may
be useful if insulin is reconsidered (ISO, 2015).
Bionix is not an ISO testing facility, so if these tests were continued, the syringe could be sent to a
testing company such as Smithers Pira who tests prefilled syringes using some of the previously mentioned
ISO standards. Smithers Pira analyzes syringe dimensions including the barrel, stopper, plunger, label, and
graduation lines. Syringe performance, integrity, and resistance is determined based on various forces to
inject and break with the dosing accuracy and residual volume. System compatibility is determined based
on the assembly and deploying mechanism and ease of use. Shelf-life is determined with real time and
accelerated aging in environmental conditions. Finally different syringe transport situations are simulated
for vibration, pressure, and temperature (SMITERS GROUP, 2015). Syringes that can withstand and
perform adequately under these conditions are considered mechanically safe.
After mechanical testing was complete, the biological response would be analyzed with ISO 10993.
In this standard evaluation, genotoxicity, carcinogenicity, and reproductive toxicity would be tested. Other
tests would include interaction with blood, in vitro cytotoxicity such as viability and proliferation studies,
local inflammatory effects, sterilization processes, degradation products, skin sensitivity, and systemic
toxicity (ISO, 2015).
After the bench testing is completed, clinical studies would need to be completed. Because the
components of the syringe that contact the patient and the drug are not novel, it might be possible to bypass
much of the testing with an FDA 510k exemption.
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Additional
Standardized functional requirements are displayed in Table 4, and constraints and limitations are displayed
in Table 5.
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Appendix
Table 1: Results of surveys showing the percent of people surveyed responding yes to each question displayed.

Question

% Answering Yes

Do you use a prefilled syringe?
Is the prefilled syringe an autoinjector?
Do you ever need to travel with the syringe?
Have you encountered a time when it was difficult to bring your syringe?
Do you find your syringe is too big or not portable enough?
Is your syringe conspicuous or embarrassing to use?
Does your syringe require temperature specific environments?
Do you appreciate color-codes?
Does your syringe ever malfunction?
Does your syringe ever accidentally deploy?
Have you ever accidentally stuck yourself with the needle?
Does your syringe require lots of dexterity?
Do you ever struggle to deploy your syringe?
Does your syringe require a specific injection site?

88.9
55.6
88.9
44.4
22.2
55.6
100.0
77.8
55.6
11.1
44.4
22.2
22.2
88.9

Figure 1: Bar chart showing the most prominent results from the prefilled syringe user survey.
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Figure 2: SolidWorks model showing the basic concept for our first design that was considered, the prefilled syringe
with folding plunger.

Figure 3: SolidWorks model showing the basic concept for the second design that was considered, a prefilled syringe
with telescoping plunger component.
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Figure 4: SolidWorks model showing the basic concept of the third design that was considered, a prefilled syringe
with a separate screw-on plunger.
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Figure 5: SolidWorks models showing two views of the preliminary folding syringe design with the added features
of quarter-locks, the incorporation of pins, and clips to prevent premature syringe deployment.
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Figure 6: SolidWorks models showing first syringe prototype, including step to prevent premature deployment.
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Figure 7: SolidWorks model showing the final prototype that was considered and
ordered with correct dimensions.

Table 2: Pressure calculations used to determine
appropriate forces that would be applied to syringe for
mechanical simulations.
Time (s) Q (mL/s)
P1 (MPa)
P1 (atm)
1.25

2.4

7.58

75.8

2.5

1.2

1.91

19.1

5

0.6

0.49

4.9

7.5

0.4

0.23

2.3

10

0.3

0.13

1.3

Table 3: Assumed mechanical properties that were used for SolidWorks simulations.
AISI 321 Annealed
Low-Density
Polyisoprene
Stainless Steel
Polyethylene
1.93 x 1011
3.00 x 1011
1.15 x 109
Elastic Modulus

Units
Pa

Poisson's Ratio

0.27

0.45

0.50

(Unitless)

Shear Modulus

-

2.25 x 1011

3.82 x 108

Pa

Mass Density

8000

919

906

kg/m^3

Tensile Strength
Compressive Strength
Yield Strength

6.20 x 10

8

2.34 x 10

8

1.00 x 10

10

1.00 x 10

10

1.75 x 10

10

2.00 x 10

10

Pa

2.00 x 10

10

Pa

9

Pa

5.00 x 10
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Figure 8: The assembly used for the mechanical testing is shown. The long, red
arrows demonstrate where the pressures are begin applied. The clusters of short,
green arrows demonstrated which faces were “fixed.”

Figure 9: Visualization of the nodes used in the mechanical testing simulation.
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Figure 10: The factor of safety has been plotted as a function of the time that it takes to inject 3 mL of fluid into a
patient with normal blood pressure. The minimum factor of safety was 14 at t = 1.25 seconds.

Figure 11: The maximum stresses occur along the syringe body (indicated by the green
color). Additional high-stress areas occur along the center of the shaft and as stress
concentrations in the corners of the notches in the shaft.
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Figure 12: Strain intensities within the syringe assembly. The maximum strains occur
primarily within the plunger.

Table 4: Functional requirements for the prefilled syringe. * Indicates that, although first determined to be a functional
requirement during team brainstorming, this functional requirement was further considered by evaluating the results
of our survey distributed to users of prefilled syringes.
Functional
Requirement

Reasoning

Biocompatible
material

3 members of the team have recently completed the Advanced Biomaterials course,
which forced strategies for reducing foreign body response to our syringe and needle into
our minds. If the syringe causes a negative response when in contact with the body, it
cannot be used for its intended purpose.

Material does not
absorb drugs

This requirement was also developed as a response to the above mentioned course. If the
drugs absorb (stick to) the walls of the syringe body, it cannot be delivered through the
needle.

Lightweight*

Our literature searches looked deeply into reasons as to why patients who use prefilled
syringe products often stray from their treatment regimen. Difficulty carrying prefilled
syringes on his or her person was a reason patients are dissatisfied with current products,
and as a result we intend to account for this with our new design.

Withstand differences
in storage
temperature*

This requirement was developed in response to pursue an insulin delivery device.
Insulin, and other drugs, often require refrigeration or specific storage temperatures.
Therefore, the material used to create our device must be capable of being transported
between these conditions.
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Withstand mechanical
forces without
breaking

Varying amounts of force will be applied to the syringe, particularly the plunger and
syringe body, during use. This force will be dependent on the context in which the
syringe is used and the physique of the user. The syringe must withstand the largest
amount of pressure that can reasonably be applied during use.

Reliable dosage*

With drugs such as insulin, which often require varying doses per user, it is important
that the syringe is able to be tuned to deliver the correct amount.

Stores a consistent
volume

Similar to dosing, the syringe must be able to store all of the required volume of drug
without taking up unused space.

Dispenses a consistent
volume

For a single-dosing syringe, it is crucial that the device dispenses the required amount
of drug or vaccine.

Inconspicuous*

One prominent reason why patients do not always maintain their treatment as directed is
that they are embarrassed or uncomfortable to use their prefilled syringe to administer
drugs in public. We will make our syringe inconspicuous as to make users more
comfortable.

Easy to dispose of

For a single-use syringe, the device must be easy to dispose of and not contain harmful
components.

Compliant with
regulations

Use and disposal of such syringe devices must comply with institutional regulations as
well as those put forth by the FDA.

Design Feature

Reasoning

Molded pins

If pins are molded into other components, number of total parts decreases.

¼ turn locks

Including ¼ turn locks in the device ensures that the person completes this step before
using the device, preventing accidental deployment.

Snap piece

In folded position, the plunger snaps into the syringe body for safe storage.
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Step piece

Inclusion of the step piece, as requested by Bionix, prevents accidental deployment.

Table 5: Constraints and limitations for the prefilled syringe.
Customer Constraints

Customer Constraint

Reasoning

Bionix

Bionix has requested that we develop this product and as a result we are constrained by
the criteria they provide for this project.

Prefilled syringe users

People with diabetes, allergies, or other conditions mandating drug delivery via
injection must be able to use this product safely and effectively.

Healthcare personnel

Doctors, nurses, pharmacists, and emergency medical technicians must know how to
safely and effectively administer emergency medications and vaccinations using this
product.

Parents and caregivers
of children

People taking care of children, including teachers, babysitters, and school nurses, must
be able to use this product in order to provide children with their medications.

Military personnel

Retirement and
assisted living facility
personnel

Military personnel must be able to quickly administer medications in emergency
situations.

People caring for elderly individuals must be able to help them administer insulin and
other drugs.

Design Constraints and Limitations

Constraint/Limitation

Injection time

Reasoning

For use in emergency situations, we should design the device in such a way that drugs
can be administered quickly.
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Cost of device

Structure of device

Dispensation

Decreased
plunger/button/trigger
size

Inconspicuous

Regulatory compliance

Color codes

The device must be as inexpensive as possible for the manufacturer(s) to make, drug
companies to purchase for filling, and for customers to purchase.

The device must be lightweight to facilitate being easy to travel with, but must
withstand pressure and temperature changes during travel, storage, and use.

The device must dispense the appropriate amount of drug for either a single-use or
multiuse application.

Bionix has requested that we decrease the overall size of the syringe and we decided
this will be best accomplished by decreasing the size of the plunger/button/trigger.

The device should be inconspicuous to facilitate patient compliance.

The device, its use, and its disposal must comply with both institutional and FDA
regulations.

For multiuse in insulin delivery applications, users reported via our survey to
appreciate color coded dials to change the delivery.

Timeline
Stringent syringes hit many major milestones throughout the project from October 2014 through
April 2015. Throughout the process, the notebook was continually assembled. The team information was
developed during October. The literature was preliminarily reviewed during November. During this review,
the definition of the problem, problem statement, objective tree, and functional requirements were
determined and revised in November. The group developed a survey to help define customer opinions, an
anonymous survey was conducted and analyzed starting in October and was continued through the end of
February. Starting in January, Stringent Syringes began detailing design options. In January, the preliminary
concepts were approved with Bionix, specific design parameters and materials were more thoroughly
researched, SolidWorks models were created, and a final design concept was chosen. In February, testing
methods and similar patents were researched for future use. By the middle of March, a prototype was
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ordered from a 3D printing company, Shapeways. In tandem with the prototyping, simulation testing was
performed on the finalized SolidWorks design. During this process, Stringent Syringes regularly met with
Bionix every other week and we met with our advisor three times (corresponding with three progress
reports). Table 6 shows Stringent Syringes’ Gantt chart as a detailed schedule throughout the design
process.

Table 6: Detailed timeline of Stringent Syringes design process as task list of the Gantt chart.
PIC (blank
Task
Start Date
= all)

Finish Date

1

Team Information

14-Oct-14

11-Nov-14

1.1

Team Introductions

14-Oct-14

11-Nov-14

1.2

Create team name

14-Oct-14

14-Oct-14

1.3

Decide that Doodle pools are best way to plan meeting days
and times

14-Oct-14

14-Oct-14

1.4

Coordinate meeting times

11-Nov-14

11-Nov-14

1.5

Write team member expectations

20-Oct-14

6-Nov-14

1.6

Define team mission statement

20-Oct-14

6-Nov-14

1.7

Define group goals

20-Oct-14

6-Nov-14

2

Literature review of topic

16-Oct-14

21-Nov-14

2.1

Primary literature review

16-Oct-14

6-Nov-14

2.2

Independent literature mini review on cost of syringes

Katie

4-Nov-14

21-Nov-14

2.3

Independent literature mini review on design of syringes

Cale

4-Nov-14

21-Nov-14

2.4

Independent literature mini review on design of syringes

Sarah

4-Nov-14

21-Nov-14

2.5

Independent literature mini review on uses of syringes

Jen

4-Nov-14

21-Nov-14

Connect with Bionix

16-Oct-14

1-May-15

3.1

Come up with questions for customer

16-Oct-14

20-Oct-14

3.2

Preliminary literature search before meeting with customer

16-Oct-14

20-Oct-14

3.3

Meet with customer

20-Oct-14

20-Oct-14

3.4

Send 1st (fall) progress report to Bionix

6-Nov-14

5-Dec-14

3.5

Meet with Bionix every other week for updates (spring)

20-Jan-15

27-Apr-15

3

Katie

Katie
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3.6

Send Spring Progress Report I

Sarah

2-Feb-15

6-Feb-15

3.7

Revise Gantt Chart for Progress Report II

Katie

23-Feb-15

27-Feb-15

3.8

Send Spring Progress Report II

Sarah and
Katie

2-Mar-15

6-Mar-15

3.9

Revise Gantt Chart for Progress Report III

Katie

30-Mar-15

3-Apr-15

3.10

Send Spring Progress Report III

Cale

6-Apr-15

10-Apr-15

3.11

Send Final Report

Katie

27-Apr-15

1-May-15

13-Oct-14

2-Dec-14

4

Fall semester reports and notebook

4.1

Assemble preliminary notebooks and turn in to Dr. V.

Katie

13-Oct-14

6-Nov-14

4.2

Complete Fall Progress Report I

Cale

13-Oct-14

5-Dec-14

4.3

Assemble, complete, and turn in final fall project notebooks
to Dr. V.

Sarah

14-Oct-14

2-Dec-14

Preliminary definition of problem and requirements

20-Oct-14

6-Nov-14

5.1

Develop preliminary definition of problems and
requirements

20-Oct-14

6-Nov-14

5.2

Define problem statement

20-Oct-14

6-Nov-14

5.3

Develop preliminary objective tree

20-Oct-14

6-Nov-14

5.4

Develop preliminary list of functional requirements

20-Oct-14

6-Nov-14

Revise preliminary notebook

18-Nov-14

21-Nov-14

5

6
6.1

Revise functional requirements

Cale

18-Nov-14

21-Nov-14

6.2

Finalize objective tree

Sarah

18-Nov-14

21-Nov-14

6.3

Revise team member expectations

Katie

18-Nov-14

21-Nov-14

6.4

Revise agendas and minutes

Sarah

18-Nov-14

21-Nov-14

14-Oct-14

27-Feb-15

Katie

14-Oct-14

13-Nov-14

7

Customer survey

7.1

Create customer survey

7.2

Distribute customer survey (round 1)

Jen

13-Nov-14

28-Nov-14

7.3

Analyze results from customer survey

Sarah

28-Nov-14

2-Dec-14

7.4

Redistribute customer survey

Jen

20-Jan-15

24-Feb-15

7.5

Analyze final results from customer survey

Sarah

24-Feb-15

27-Feb-15

29-Oct-14

2-Dec-14

7-Jan-15

30-Jan-15

7-Jan-15

12-Jan-15

8

Define client and engineering constraints and limitations

9

Revise fall notebook

9.1

Determine spring meeting time for group

Katie
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9.2

Determine spring meeting time for Bionix

Katie

7-Jan-15

12-Jan-15

9.3

Review notebook and report comments

Cale

13-Jan-15

13-Jan-15

9.4

Revise team member expectations

Katie

13-Jan-15

30-Jan-15

9.5

Revise agendas and minutes

Katie

13-Jan-15

30-Jan-15

9.6

Revise Gantt Chart for Spring Progress Report I

Katie

13-Jan-15

30-Jan-15

10

Develop prototype

13-Jan-15

20-Mar-15

10.1

Determine our design options for Bionix

Jen

13-Jan-15

13-Jan-15

10.2

Approve preliminary concepts with Bionix

Cale

13-Jan-15

20-Jan-15

10.3

Research specific design parameters and materials

Sarah and
Katie

20-Jan-15

3-Feb-15

10.4

Develop SolidWorks models

Cale

20-Jan-15

3-Feb-15

10.5

Approve final concept with Bionix

Sarah

20-Jan-15

3-Feb-15

10.6

Research and develop testing methods

Sarah

3-Feb-15

3-Mar-15

10.7

Research ISO testing

Katie

10-Feb-15

17-Feb-15

10.8

Research similar patents

Sarah

10-Feb-15

17-Feb-15

10.9

Research prototyping companies

Jen

10-Feb-15

24-Feb-15

10.10

Finalize SolidWorks model with Bionix

Cale

3-Feb-15

17-Feb-15

10.11

Finalize SolidWorks model

Cale

3-Feb-15

24-Feb-15

10.12

Create prototype 1

Jen

24-Feb-15

14-Mar-15

10.13

Mechanical testing in SolidWorks

Cale

9-Mar-15

13-Mar-15

10.14

Revise prototype and order new one

17-Mar-15

31-Mar-15

10.15

Test the prototype

31-Mar-15

10-Apr-15

10.16

Analyze test results

18-Mar-15

10-Apr-15

12-Jan-15

1-May-15

Sarah

30-Jan-15

2-Feb-15

11

Cale and
Jen
Katie and
Sarah
Katie

Spring semester reports and meetings

11.1

Submit Spring Progress Report I

11.2

Progress Report Meeting I

All

2-Feb-15

6-Feb-15

11.3

Submit Spring Progress Report II

Jen

27-Feb-15

2-Mar-15

11.4

Progress Report Meeting II

All

2-Mar-15

6-Mar-15

11.5

Submit Spring Progress Report III

Cale

3-Apr-15

6-Apr-15

11.6

Progress Report Meeting III

All

6-Apr-15

10-Apr-15

29

11.7

Assemble and complete spring notebook (with fall
notebook)

11.8

Prepare final presentation

11.9

Submit Final Progress Report, notebook, presentation, and
team evaluations

12

Submit full version of Honors Research Project Report to
Sponsor

12.2

Respond to Sponsor revisions and edits

12.3

Submit full version of Honors Research Project Report to
two Readers

12.4

Respond to Readers revisions and edits

12.5

Obtain Sponsor and Readers signatures for the report

12.7

12-Jan-15

1-May-15

All

8-Apr-15

1-May-15

Katie

27-Apr-15

1-May-15

20-Mar-15

17-Apr-15

20-Mar-15

1-Apr-15

7-Apr-15

9-Apr-15

9-Apr-15

10-Apr-15

13-Apr-15

15-Apr-15

Jen

15-Apr-15

17-Apr-15

Jen

15-Apr-15

16-Apr-15

Cale

16-Apr-15

17-Apr-15

Honors College deadlines

12.1

12.6

Katie

Submit the final version to the Department Chair for
signature
Final submission of abstract and report to Honors College
with one page summary of individual work

Katie

Sarah

Budget
Our allotted budget was used to create the design prototypes. The prototype was determined a
significant part of the process, allowing us to determine function and validation as well as demonstrate
these features. Our design was sent to a 3D printing company, Shapeways, made out of ultra-detailed frosted
plastic. Our first model was $29.06. Upon arrival, a dimension error was noted, corrected, and the model
was reprinted with the same material. The second model was $39.64. Given these costs, we are well within
our budget for this project.
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